Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Genomic Vision S.A. buy metanicnor

Start price
€15.80
24.02.15 / 50%
Target price
€17.00
24.08.15
Performance (%)
-19.62%
End price
€12.70
24.08.15
Summary
This prediction ended on 24.08.15 with a price of €12.70. The price of Genomic Vision S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.62%. metanicnor has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Genomic Vision S.A. - - - -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by metanicnor for this prediction

In the thread Genomic Vision S.A. diskutieren
Prediction Buy
Perf. (%) -19.62%
Target price 17.000
Change
Ends at 24.08.15

gv

Biotechnologie-Unternehmen, spezialisiert auf die Entwicklung und den Verkauf von molekulargenetische Untersuchungen durch molekularen Kämmen, die Variationen in Genen erkennt

sie hat bereits einen Partner, der Vereinigten Staaten Quest Diagnostics, Partnerschaft nur zu 3 Jahren "mit einem signifikanten Anstieg der Lizenzgebühren auf kommenden Auktionen Tests durch molekulares Kämmen", so die offizielle Erklärung verlängern

2 neue Tests sollen im Jahr 2015 in Verkehr gebracht werden

http://bfmbusiness.bfmtv.com/mediaplayer/video/genomic-vision-aux-etats-unis-une-nouvelle-etape-dans-son-partenariat-avec-quest-diagnostics-aaron-bensimon-34-0702-439873.html

Dank für den folgenden Link MadameButterfly: Genomic Vision hat große Augen molekularen Kämmen Technologie für das Jahr 2015

4. Februar 2015 | Von Emily Wasserman
http://www.fiercediagnostics.com/story/genomic-vision-eyes-big-2015-molecular-combing-technology/2015-02-04?utm_medium=nl&utm_source=internal

FYI: Bryan Garnier ist 23 €, ist Kepler Cheuvreux 17.5 €, hat Societe Generale ein Kursziel von 19 € & $ 17 €

Prediction Buy
Perf. (%) -19.62%
Target price 17.000
Change
Ends at 24.08.15

(Laufzeit überschritten)

Stopped prediction by metanicnor for Genomic Vision S.A.

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.29
02.03.19
€0.80
04.11.21
216.67%
22.11.20

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.81
29.08.18
€2.20
28.02.19
-63.44%
28.02.19

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€2.86
28.02.18
€8.00
29.08.18
-72.68%
29.08.18

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€2.82
29.08.17
€8.00
28.02.18
1.77%
28.02.18

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€5.00
28.02.17
€8.75
28.08.17
-42.20%
28.08.17

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€4.77
26.08.16
€8.75
27.02.17
2.52%
27.02.17

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€6.30
25.02.16
€17.00
25.08.16
-22.54%
25.08.16

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€11.90
24.08.15
€17.00
24.02.16
-46.55%
24.02.16

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€14.60
17.02.15
€15.80
24.02.15
9.25%
24.02.15

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€12.63
03.02.15
€14.00
17.02.15
11.56%
17.02.15

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€13.21
04.08.14
€17.00
03.02.15
-6.15%
03.02.15